- Home
- MYGN vs BRBI Comparison
MYGN vs BRBI Comparison
Compare MYGN & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MYGN | BRBI |
|---|---|---|
| Founded | 1991 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.6M | 394.5M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | MYGN | BRBI |
|---|---|---|
| Price | $5.10 | $14.92 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $7.64 | N/A |
| AVG Volume (30 Days) | ★ 1.4M | 1.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.95% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $7.19 | $33.39 |
| Revenue Next Year | $5.64 | $17.24 |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.76 | $12.54 |
| 52 Week High | $10.47 | $67.01 |
Technical Indicators
Market Signals| Indicator | MYGN | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 51.24 | 52.36 |
| Support Level | $5.02 | $12.85 |
| Resistance Level | $5.67 | $14.97 |
| Average True Range (ATR) | 0.39 | 0.23 |
| MACD | 0.10 | -0.05 |
| Stochastic Oscillator | 63.35 | 60.75 |
Price Performance
Historical ComparisonAbout MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
About BRBI BRBI BR Partners S.A. ADSs
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered.